Chemoinformaics analysis of TRANS-COMMUNIC-ACID-METHYL-ESTER
| Molecular Weight | 316.485 | nRot | 4 |
| Heavy Atom Molecular Weight | 284.229 | nRig | 15 |
| Exact Molecular Weight | 316.24 | nRing | 2 |
| Solubility: LogS | -5.086 | nHRing | 0 |
| Solubility: LogP | 5.222 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 58.0114 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.391 |
| Synth | 4.276 |
| Natural Product Likeliness | 3.096 |
| NR-PPAR-gamma | 0.169 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.909 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.712 |
| MDCK | 0.0000161 |
| BBB | 0.118 |
| PPB | 0.857625 |
| VDSS | 1.562 |
| FU | 0.106222 |
| CYP1A2-inh | 0.077 |
| CYP1A2-sub | 0.669 |
| CYP2c19-inh | 0.266 |
| CYP2c19-sub | 0.944 |
| CYP2c9-inh | 0.286 |
| CYP2c9-sub | 0.536 |
| CYP2d6-inh | 0.102 |
| CYP2d6-sub | 0.909 |
| CYP3a4-inh | 0.835 |
| CYP3a4-sub | 0.559 |
| CL | 10.94 |
| T12 | 0.078 |
| hERG | 0.017 |
| Ames | 0.01 |
| ROA | 0.089 |
| SkinSen | 0.119 |
| Carcinogencity | 0.128 |
| EI | 0.143 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.484 |
| Antiviral | No |
| Prediction | 0.55094 |